Sartorius Stedim Biotech S.A.
SDMHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,780,000 | $2,775,500 | $3,492,700 | $2,886,977 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Cost of Goods Sold | $1,573,300 | $1,542,000 | $1,658,200 | $1,333,974 |
| Gross Profit | $1,206,700 | $1,233,500 | $1,834,500 | $1,553,003 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| R&D Expenses | $144,100 | $129,500 | $132,400 | $110,491 |
| G&A Expenses | $168,700 | $167,100 | $154,700 | $126,117 |
| SG&A Expenses | $648,500 | $616,200 | $601,200 | $531,764 |
| Sales & Mktg Exp. | $479,800 | $449,100 | $446,500 | $405,647 |
| Other Operating Expenses | $43,500 | $0 | $1,700 | $1,752 |
| Operating Expenses | $836,100 | $770,900 | $751,700 | $670,022 |
| Operating Income | $370,600 | $449,500 | $995,200 | $865,421 |
| % Margin | 13.3% | 16.2% | 28.5% | 30% |
| Other Income/Exp. Net | -$151,400 | -$48,400 | $135,200 | -$218,721 |
| Pre-Tax Income | $219,200 | $401,100 | $1,130,400 | $646,720 |
| Tax Expense | $40,700 | $89,000 | $250,500 | $232,411 |
| Net Income | $175,100 | $309,700 | $876,100 | $414,400 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS | 1.81 | 3.36 | 9.51 | 4.5 |
| % Growth | -46.1% | -64.7% | 111.3% | – |
| EPS Diluted | 1.81 | 3.36 | 9.51 | 4.5 |
| Weighted Avg Shares Out | 96,777 | 92,161 | 92,163 | 92,177 |
| Weighted Avg Shares Out Dil | 96,777 | 92,161 | 92,163 | 92,177 |
| Supplemental Information | – | – | – | – |
| Interest Income | $19,566 | $6,200 | $500 | $276 |
| Interest Expense | $164,496 | $117,000 | $18,600 | $10,398 |
| Depreciation & Amortization | $301,700 | $237,600 | $181,700 | $141,556 |
| EBITDA | $670,500 | $755,700 | $1,330,700 | $798,700 |
| % Margin | 24.1% | 27.2% | 38.1% | 27.7% |